Newsfeeds - Spark Newswire

1 minute read

Fluidigm Q2 EPS $(0.12) Beats $(0.20) Estimate, Sales $31.00M Beat $30.57M Estimate

Today, 3:20 PM

Fluidigm (NASDAQ:FLDM) reported quarterly losses of $(0.12) per share which beat the analyst consensus estimate of $(0.20) by 40 percent. This is a 71.43 percent decrease over losses of $(0.07) per share from the same

FLDM

2 minute read

Fluidigm Reports Co-Marketing Deal With Ultivue For Biomarker Imaging Solutions For Precision Medicine, No Terms Disclosed

By Benzinga Newsdesk

Today, 3:20 PM

Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced a co-marketing agreement with Ultivue, Inc., under which

FLDM

34 minute read

Earnings Scheduled For August 5, 2021

By Benzinga Insights

Today, 3:20 PM

Companies Reporting Before The Bell • OneSpaWorld Holdings (NASDAQ:OSW) is projected to report quarterly loss at $0.20 per share on revenue of $6.42 million.

AAOI

2 minute read

Movers

Unusual Options Activity Insight: Fluidigm

By Benzinga Insights

Today, 3:20 PM

Shares of Fluidigm (NASDAQ:FLDM) saw some unusual options activity on Wednesday. Following the unusual option alert, the stock price moved down to $6.94.

FLDM

1 minute read

News

‘The Advanta SARS-CoV-2 Mutation Assay Panel can be used to identify the Delta+ variant and infer the Delta variant from prevailing epidemiology…’ -Tweet from Fluidigm

By Benzinga Newsdesk

Today, 3:20 PM

https://twitter.com/fluidigm/status/1422662017685409793

FLDM

1 minute read

Legal
News

Fluidigm Granted U.S. Patent Titled ‘Methods and kits for extracting nucleic acids from paraffin embedded samples’

By Benzinga Newsdesk

Today, 3:20 PM

https://patft.uspto.gov/netacgi/nph-Parser?Sect1=PTO2&Sect2=HITOFF&u=%2Fnetahtml%2FPTO%2Fsearch-adv.htm&r=5324&f=G&l=50&d=PTXT&p=107&S1=20210803&OS=20210803&RS=20210803

FLDM

6 minute read

62 Biggest Movers From Yesterday

By Lisa Levin

Today, 3:20 PM

Gainers

AEI

3 minute read

Rover Labs To Provide COVID-19 Testing To 50 NYC Public Schools Using Fluidigm Technology

By Bill Haddad

Today, 3:20 PM

Rover Labs, a diagnostics technology leader in end-to-end saliva testing, is providing saliva-based COVID-19 testing to approximately 50 New York City public schools during a two-month pilot program that began

FLDM

4 minute read

Uncategorized

56 Biggest Movers From Yesterday

By Lisa Levin

Today, 3:20 PM

Gainers Bridgford Foods Corporation (NASDAQ: BRID) shares surged 46.2% to close at $20.74 on Tuesday.

ADES

4 minute read

Uncategorized

Fluidigm Shares Moved Higher Earlier; Co Says Data Published In Nature Communications Demonstrate Power Of Co’s CyTOF And Imaging Mass Cytometry Technologies

By Benzinga Newsdesk

Today, 3:20 PM

Fluidigm Corporation (NASDAQ:FLDM), an innovative biotechnology tools provider with a vision to improve life through comprehensive health insight, today announced the publication of data that further validate the

FLDM